Advertisement

Tobacco

  • Vicki Myers
  • Laura Rosen
  • Yariv GerberEmail author
Chapter
  • 614 Downloads

Abstract

Overwhelming epidemiological and pathophysiological evidence has shown that smokers are at significantly increased risk of developing acute coronary syndromes, while those with established cardiovascular disease have lower odds of survival. This chapter discusses the impact of firsthand, secondhand, and thirdhand exposure to tobacco smoke, as well as smokeless tobacco, on the development and progression of cardiovascular disease. Citing numerous examples, we demonstrate the extent of the cardiovascular damage caused not only to smokers themselves but to those around them and the processes by which these changes happen. Smoking is the leading preventable cause of cardiovascular mortality worldwide, making this a crucial issue to address. Strategies to reduce the global burden of tobacco are examined, including smoking cessation and, more controversially, reduction, on both an individual and population level. Biological pathways are reviewed, including atherosclerosis, endothelial dysfunction, and inflammatory processes, and methodological issues in the literature are addressed.

Keywords

Smoking Cardiovascular disease Secondhand exposure Thirdhand exposure Smoking cessation Smoking reduction Mortality 

References

  1. Ambrose JA, Barua RS (2004) The pathophysiology of cigarette smoking and cardiovascular disease: an update. J Am Coll Cardiol 43(10):1731–1737PubMedCrossRefGoogle Scholar
  2. Attebring M, Herlitz J, Berndt AK, Karlsson T, Hjalmarson A (2001) Are patients truthful about their smoking habits? A validation of self-reports about smoking cessation with biochemical markers of smoking activity amongst patients with ischemic heart disease. J Int Med 249(2):145–151CrossRefGoogle Scholar
  3. Barnoya J, Glantz SA (2005) Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation 111(20):2684–2698PubMedCrossRefGoogle Scholar
  4. Barutcu I, Esen AM, Degirmenci B, Acar M, Kaya D, Turkmen M, Melek M, Onrat E, Esen OB, Kirma C (2004) Acute cigarette smoking-induced hemodynamic alterations in the common carotid artery – a transcranial Doppler study. Circ J 68(12):1127–1131PubMedCrossRefGoogle Scholar
  5. Bjartveit K, Tverdal A (2005) Health consequences of smoking 1-4 cigarettes per day. Tob Control 14(5):315–320PubMedCrossRefGoogle Scholar
  6. Blache D, Bouthillier D, Davignon J (1992) Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin. Atherosclerosis 93(3):179–188PubMedCrossRefGoogle Scholar
  7. Blann AD, Kirkpatrick U, Devine C, Naser S, McCollum CN (1998) The influence of acute smoking on leucocytes, platelets and the endothelium. Atherosclerosis 141(1):133–139PubMedCrossRefGoogle Scholar
  8. Bowman TS, Gaziano JM, Buring JE, Sesso HD (2007) A prospective study of cigarette smoking and risk of incident hypertension in women. J Am Coll Cardiol 50(21):2085–2092PubMedCrossRefGoogle Scholar
  9. Callinan JE, Clarke A, Doherty K, Kelleher C (2010) Legislative smoking bans for reducing secondhand smoke exposure, smoking prevalence and tobacco consumption. Cochrane Database Syst Rev (4):CD005992Google Scholar
  10. Chen CY, Chow D, Chiamvimonvat N, Glatter KA, Li N, He Y, Pinkerton KE, Bonham AC (2008) Short-term secondhand smoke exposure decreases heart rate variability and increases arrhythmia susceptibility in mice. Am J Physiol Heart Circ Physiol 295(2):H632–H639PubMedCrossRefGoogle Scholar
  11. Craig WY, Palomaki GE, Haddow JE (1989) Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 298(6676):784–788PubMedCrossRefGoogle Scholar
  12. Davis JW, Shelton L, Eigenberg DA, Hignite CE, Watanabe IS (1985) Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 37(5):529–533PubMedCrossRefGoogle Scholar
  13. Davis JW, Hartman CR, Shelton L, Ruttinger HA (1986) Smoking-induced changes in endothelium and platelets are not affected by hydroxyethylrutosides. Br J Exp Pathol 67(5):765–771PubMedGoogle Scholar
  14. Direk N, Newson RS, Hofman A, Kirschbaum C, Tiemeier H (2011) Short and long-term effects of smoking on cortisol in older adults. Int J Psychophysiol 80(2):157–160PubMedCrossRefGoogle Scholar
  15. Doll R, Peto R, Boreham J, Sutherland I (2004) Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ 328(7455):1519PubMedCrossRefGoogle Scholar
  16. Doyle JT, Dawber TR, Kannel WB, Heslin AS, Kahn HA (1962) Cigarette smoking and coronary heart disease. Combined experience of the Albany and Framingham studies. N Engl J Med 26:796–801CrossRefGoogle Scholar
  17. Escobedo LG, Caspersen CJ (1997) Risk factors for sudden coronary death in the United States. Epidemiology 8(2):175–180PubMedCrossRefGoogle Scholar
  18. Ezzati M, Lopez AD (2003) Estimates of global mortality attributable to smoking in 2000. Lancet 362(9387):847–852PubMedCrossRefGoogle Scholar
  19. Ezzati M, Henley SJ, Thun MJ, Lopez AD (2005) Role of smoking in global and regional cardiovascular mortality. Circulation 112(4):489–497PubMedCrossRefGoogle Scholar
  20. Fortmann SP, Haskell WL, Williams PT (1986) Changes in plasma high density lipoprotein cholesterol after changes in cigarette use. Am J Epidemiol 124(4):706–710PubMedGoogle Scholar
  21. Garland C, Barrett-Connor E, Suarez L, Criqui MH, Wingard DL (1985) Effects of passive smoking on ischemic heart disease mortality of nonsmokers. A prospective study. Am J Epidemiol 121(5):645–650PubMedCrossRefGoogle Scholar
  22. Gerber Y, Rosen LJ, Goldbourt U, Benyamini Y, Drory Y, Israel Study Group on First Acute Myocardial Infarction (2009) Smoking status and long-term survival after first acute myocardial infarction. J Am Coll Cardiol 54(25):2382–2387PubMedCrossRefGoogle Scholar
  23. Gerber Y, Myers V, Goldbourt U (2012) Smoking reduction at midlife and lifetime mortality risk in men: a prospective cohort study. Am J Epidemiol 175(10):1006–1012PubMedCrossRefGoogle Scholar
  24. Glantz SA (2008) Meta-analysis of the effects of smokefree laws on acute myocardial infarction: an update. Prev Med 47(4):452–453PubMedCrossRefGoogle Scholar
  25. Godtfredsen NS, Osler M, Vestbo J, Andersen I, Prescott E (2003) Smoking reduction, smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Denmark 1976-1998: a pooled cohort study. J Epidemiol Community Health 57(6):412–416PubMedCrossRefGoogle Scholar
  26. Godtfredsen NS, Prescott E, Vestbo J, Osler M (2006) Smoking reduction and biomarkers in two longitudinal studies. Addiction 101(10):1516–1522PubMedCrossRefGoogle Scholar
  27. Gorber SC, Schofield-Hurwitz S, Hardt J, Levasseur G, Tremblay M (2009) The accuracy of self-reported smoking: a systematic review of the relationship between self-reported and cotinine-assessed smoking status. Nicotine Tob Res 11:12–24CrossRefGoogle Scholar
  28. Gottlieb S, Fallavollita J, McDermott M, Brown M, Eberly S, Moss AJ (1994) Cigarette smoking and the age at onset of a first non-fatal myocardial infarction. Coron Artery Dis 5(8):687–694PubMedCrossRefGoogle Scholar
  29. Grundtvig M, Hagen TP, German M, Reikvam A (2009) Sex-based differences in premature first myocardial infarction caused by smoking: twice as many years lost by women as by men. Eur J Cardiovasc Prev Rehabil 16(2):174–179PubMedCrossRefGoogle Scholar
  30. Grundtvig M, Hagen TP, Amrud ES, Reikvam A (2011) Mortality after myocardial infarction: impact of gender and smoking status. Eur J Epidemiol 26(5):385–393PubMedCrossRefGoogle Scholar
  31. Hamer M, Stamatakis E, Kivimaki M, Lowe GD, Batty GD (2010) Objectively measured secondhand smoke exposure and risk of cardiovascular disease: what is the mediating role of inflammatory and hemostatic factors? J Am Coll Cardiol 56(1):18–23PubMedCrossRefGoogle Scholar
  32. He J, Vupputuri S, Allen K, Prerost MR, Hughes J, Whelton PK (1999) Passive smoking and the risk of coronary heart disease: a meta-analysis of epidemiologic studies. N Engl J Med 340(12):920–926PubMedCrossRefGoogle Scholar
  33. Hein HO, Suadicani P, Skov P, Gyntelberg F (1991) Indoor dust exposure: an unnoticed aspect of involuntary smoking. Arch Environ Health 46(2):98–101PubMedCrossRefGoogle Scholar
  34. Heiss C, Amabile N, Lee AC, Real WM, Schick SF, Lao D, Wong ML, Jahn S, Angeli FS, Minasi P, Springer ML, Hammond SK, Glantz SA, Grossman W, Balmes JR, Yeghiazarians Y (2008) Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. J Am Coll Cardiol 51(18):1760–1771PubMedCrossRefGoogle Scholar
  35. Helsing KJ, Sandler DP, Comstock GW, Chee E (1988) Heart disease mortality in nonsmokers living with smokers. Am J Epidemiol 127(5):915–922PubMedGoogle Scholar
  36. Hill AB (1965) The environment and disease: association or causation? Proc R Soc Med 58:295–300PubMedGoogle Scholar
  37. Iso H, Shimamoto T, Sato S, Koike K, Iida M, Komachi Y (1996) Passive smoking and plasma fibrinogen concentrations. Am J Epidemiol 144(12):1151–1154PubMedCrossRefGoogle Scholar
  38. Kabat GC (2003) Fifty years’ experience of reduced-tar cigarettes: what do we know about their health effects? Inhal Toxicol 15(11):1059–1102PubMedGoogle Scholar
  39. Kallio K, Jokinen E, Raitakari OT, Hämäläinen M, Siltala M, Volanen I, Kaitosaari T, Viikari J, Rönnemaa T, Simell O (2007) Tobacco smoke exposure is associated with attenuated endothelial function in 11-year-old healthy children. Circulation 115(25):3205–3212PubMedCrossRefGoogle Scholar
  40. Kannel WB, Doyle JT, McNamara PM, Quickenton P, Gordon T (1975) Precursors of sudden coronary death. Factors related to the incidence of sudden death. Circulation 51(4):606–613PubMedCrossRefGoogle Scholar
  41. Kannel WB, D’Agostino RB, Belanger AJ (1987) Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study. Am Heart J 113(4):1006–1010PubMedCrossRefGoogle Scholar
  42. Kato T, Inoue T, Morooka T, Yoshimoto N, Node K (2006) Short-term passive smoking causes endothelial dysfunction via oxidative stress in nonsmokers. Can J Physiol Pharmacol 84(5):523–529PubMedCrossRefGoogle Scholar
  43. Kenfield SA, Wei EK, Rosner BA, Glynn RJ, Stampfer MJ, Colditz GA (2010) Burden of smoking on cause-specific mortality: application to the Nurses’ Health Study. Tob Control 19(3):248–254PubMedCrossRefGoogle Scholar
  44. Law MR, Morris JK, Wald NJ (1997) Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ 315(7114):973–980PubMedCrossRefGoogle Scholar
  45. Lee PN (1996) Mortality from tobacco in developed countries: are indirect estimates reliable? Regul Toxicol Pharmacol 24(1 Pt 1):60–68PubMedCrossRefGoogle Scholar
  46. Lightwood JM, Glantz SA (2009) Declines in acute myocardial infarction after smoke-free laws and individual risk attributable to secondhand smoke. Circulation 120(14):1373–1379PubMedCrossRefGoogle Scholar
  47. Lightwood JM, Coxson PG, Bibbins-Domingo K, Williams LW, Goldman L (2009) Coronary heart disease attributable to passive smoking: CHD Policy Model. Am J Prev Med 36(1):13–20PubMedCrossRefGoogle Scholar
  48. Mackay DF, Irfan MO, Haw S, Pell JP (2010) Meta-analysis of the effect of comprehensive smoke-free legislation on acute coronary events. Heart 96(19):1525–1530PubMedCrossRefGoogle Scholar
  49. Mähönen MS, McElduff P, Dobson AJ, Kuulasmaa KA, Evans AE, WHO MONICA Project (2004) Current smoking and the risk of non-fatal myocardial infarction in the WHO MONICA Project populations. Tob Control 13(3):244–250PubMedCrossRefGoogle Scholar
  50. Malarcher AM, Schulman J, Epstein LA, Thun MJ, Mowery P, Pierce B, Escobedo L, Giovino GA (2000) Methodological issues in estimating smoking-attributable mortality in the United States. Am J Epidemiol 152(6):573–584PubMedCrossRefGoogle Scholar
  51. Matt GE, Quintana PJ, Hovell MF, Bernert JT, Song S, Novianti N, Juarez T, Floro J, Gehrman C, Garcia M, Larson S (2004) Households contaminated by environmental tobacco smoke: sources of infant exposures. Tob Control 13(1):29–37PubMedCrossRefGoogle Scholar
  52. Matt GE, Quintana PJ, Destaillats H, Gundel LA, Sleiman M, Singer BC, Jacob P, Benowitz N, Winickoff JP, Rehan V, Talbot P, Schick S, Samet J, Wang Y, Hang B, Martins-Green M, Pankow JF, Hovell MF (2011) Thirdhand tobacco smoke: emerging evidence and arguments for a multidisciplinary research agenda. Environ Health Perspect 119(9):1218–1226PubMedCrossRefGoogle Scholar
  53. Meade T (1994) Atheroma and thrombosis in cardiovascular disease: separate or complementary? In: Marmot M, Elliott P (eds) Coronary heart disease epidemiology: from aetiology to public health. Oxford University Press, New YorkGoogle Scholar
  54. Metsios GS, Flouris AD, Angioi M, Koutedakis Y (2010) Passive smoking and the development of cardiovascular disease in children: a systematic review. Cardiol Res Pract 2011:pii587650Google Scholar
  55. Meyers DG, Neuberger JS, He J (2009) Cardiovascular effect of bans on smoking in public places: a systematic review and meta-analysis. J Am Coll Cardiol 54(14):1249–1255PubMedCrossRefGoogle Scholar
  56. Miller GJ, Bauer KA, Cooper JA, Rosenberg RD (1998) Activation of the coagulant pathway in cigarette smokers. Thromb Haemost 79(3):549–553PubMedGoogle Scholar
  57. Minami J, Ishimitsu T, Matsuoka H (1999) Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers. Hypertension 33(1 Pt 2):586–590PubMedCrossRefGoogle Scholar
  58. Mizoue T, Ueda R, Hino Y, Yoshimura T (1999) Workplace exposure to environmental tobacco smoke and high density lipoprotein cholesterol among nonsmokers. Am J Epidemiol 150(10):1068–1072PubMedCrossRefGoogle Scholar
  59. Moffatt RJ, Chelland SA, Pecott DL, Stamford BA (2004) Acute exposure to environmental tobacco smoke reduces HDL-C and HDL2-C. Prev Med 38(5):637–641PubMedCrossRefGoogle Scholar
  60. Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death in the United States, 2000. JAMA 291(10):1238–1245PubMedCrossRefGoogle Scholar
  61. Negri E, Franzosi MG, La Vecchia C, Santoro L, Nobili A, Tognoni G (1993) Tar yield of cigarettes and risk of acute myocardial infarction. GISSI-EFRIM Investigators. BMJ 306(6892):1567–1570PubMedCrossRefGoogle Scholar
  62. Oberg M, Jaakkola MS, Woodward A, Peruga A, Prüss-Ustün A (2011) Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet 377(9760):139–146PubMedCrossRefGoogle Scholar
  63. Omvik P (1996) How smoking affects blood pressure. Blood Press 5(2):71–77PubMedCrossRefGoogle Scholar
  64. Otsuka R, Watanabe H, Hirata K, Tokai K, Muro T, Yoshiyama M, Takeuchi K, Yoshikawa J (2001) Acute effects of passive smoking on the coronary circulation in healthy young adults. JAMA 286(4):436–441PubMedCrossRefGoogle Scholar
  65. Panagiotakos DB, Chrysohoou C, Pitsavos C, Papaioannou I, Skoumas J, Stefanadis C, Toutouzas P (2002) The association between secondhand smoke and the risk of developing acute coronary syndromes, among non-smokers, under the presence of several cardiovascular risk factors: the CARDIO2000 case-control study. BMC Public Health 2:9PubMedCrossRefGoogle Scholar
  66. Piano MR, Benowitz NL, Fitzgerald GA, Corbridge S, Heath J, Hahn E, Pechacek TF, Howard G, American Heart Association Council on Cardiovascular Nursing (2010) Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation 122(15):1520–1544PubMedCrossRefGoogle Scholar
  67. Pisinger C, Godtfredsen NS (2007) Is there a health benefit of reduced tobacco consumption? A systematic review. Nicotine Tob Res 9(6):631–646PubMedCrossRefGoogle Scholar
  68. Raupach T, Schäfer K, Konstantinides S, Andreas S (2006) Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm. Eur Heart J 27(4):386–392PubMedCrossRefGoogle Scholar
  69. Rohleder N, Kirschbaum C (2006) The hypothalamic-pituitary-adrenal (HPA) axis in habitual smokers. Int J Psychophysiol 59(3):236–243PubMedCrossRefGoogle Scholar
  70. Rothwell M, Rampling MW, Cholerton S, Severs PS (1991) Haemorheological changes in the very short term after abstention from tobacco by cigarette smokers. Br J Haematol 79(3):500–503PubMedCrossRefGoogle Scholar
  71. Salonen JT, Puska P, Kottke TE (1981) Smoking, blood pressure and serum cholesterol as risk factors of acute myocardial infarction and death among men in Eastern Finland. Eur Heart J 2(5):365–373PubMedGoogle Scholar
  72. Sandler DP, Comstock GW, Helsing KJ, Shore DL (1989) Deaths from all causes in non-smokers who lived with smokers. Am J Public Health 79(2):163–167PubMedCrossRefGoogle Scholar
  73. Sargent RP, Shepard RM, Glantz SA (2004) Reduced incidence of admissions for myocardial infarction associated with public smoking ban: before and after study. BMJ 328(7446):977–980PubMedCrossRefGoogle Scholar
  74. Shah RS, Cole JW (2010) Smoking and stroke: the more you smoke the more you stroke. Expert Rev Cardiovasc Ther 8(7):917–932PubMedCrossRefGoogle Scholar
  75. Sharrett AR, Sorlie PD, Chambless LE, Folsom AR, Hutchinson RG, Heiss G, Szklo M (1999) Relative importance of various risk factors for asymptomatic carotid atherosclerosis versus coronary heart disease incidence: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 149(9):843–852PubMedCrossRefGoogle Scholar
  76. Shinton R, Beevers G (1989) Meta-analysis of relation between cigarette smoking and stroke. BMJ 298(6676):789–794PubMedCrossRefGoogle Scholar
  77. Sims M, Maxwell R, Bauld L, Gilmore A (2010) Short term impact of smoke-free legislation in England: retrospective analysis of hospital admissions for myocardial infarction. BMJ 340:c2161PubMedCrossRefGoogle Scholar
  78. Spagnoli LG, Mauriello A, Palmieri G, Santeusanio G, Amante A, Taurino M (1994) Relationships between risk factors and morphological patterns of human carotid atherosclerotic plaques. A multivariate discriminant analysis. Atherosclerosis 108(1):39–60PubMedCrossRefGoogle Scholar
  79. Strong JP, Malcom GT, McMahan CA, Tracy RE, Newman WP 3rd, Herderick EE, Cornhill JF (1999) Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. JAMA 281(8):727–735PubMedCrossRefGoogle Scholar
  80. Svendsen KH, Kuller LH, Martin MJ, Ockene JK (1987) Effects of passive smoking in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 126(5):783–795PubMedGoogle Scholar
  81. Talukder MA, Johnson WM, Varadharaj S, Lian J, Kearns PN, El-Mahdy MA, Liu X, Zweier JL (2011) Chronic cigarette smoking causes hypertension, increased oxidative stress, impaired NO bioavailability, endothelial dysfunction, and cardiac remodeling in mice. Am J Physiol Heart Circ Physiol 300(1):H388–H396PubMedCrossRefGoogle Scholar
  82. Tang JL, Morris JK, Wald NJ, Hole D, Shipley M, Tunstall-Pedoe H (1995) Mortality in relation to tar yield of cigarettes: a prospective study of four cohorts. BMJ 311(7019):1530–1533PubMedCrossRefGoogle Scholar
  83. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S, INTERHEART Study Investigators (2006) Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368(9536):647–658PubMedCrossRefGoogle Scholar
  84. Thun MJ, Luiza da Costa e Silva V (2003) Introduction and overview of global tobacco surveillance. In: Shafey O, Dolwick S, Guindon GE (eds) Tobacco control country profiles, 2nd edn. American Cancer Society, AtlantaGoogle Scholar
  85. Thun MJ, Apicella LF, Henley SJ (2000) Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA 284(6):706–712PubMedCrossRefGoogle Scholar
  86. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH (1997) Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17(10):2167–2176PubMedCrossRefGoogle Scholar
  87. Tverdal A, Bjartveit K (2006) Health consequences of reduced daily cigarette consumption. Tob Control 15(6):472–480PubMedCrossRefGoogle Scholar
  88. USDHHS (1967) The health consequences of smoking: a public health service review. US Department of Health, Education and Welfare, Washington DCGoogle Scholar
  89. USDHHS (1983) The health consequences of smoking: cardiovascular disease. A report of the surgeon general. US Department of Health and Human Services, Public Health Service, Office on Smoking and Health, RockvilleGoogle Scholar
  90. USDHHS (1990) The health benefits of smoking cessation: a report of the surgeon general. U.S. Department of Health and Human Services, Public Health Service, Center for Disease Control, RockvilleGoogle Scholar
  91. USDHHS (2004) The health consequences of smoking: a report of the surgeon general. US Department of Health and Human services, Center for Disease Control and Prevention, Office on Smoking and Health, AtlantaGoogle Scholar
  92. USDHHS (2010) How tobacco smoke causes disease: the biology and behavioral basis for smoking-attributable disease: a report of the surgeon general. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health 2010, AtlantaGoogle Scholar
  93. Venn A, Britton J (2007) Exposure to secondhand smoke and biomarkers of cardiovascular disease risk in never-smoking adults. Circulation 115(8):990–995PubMedCrossRefGoogle Scholar
  94. Wells AJ (1994) Passive smoking as a cause of heart disease. J Am Coll Cardiol 24(2):546–554PubMedCrossRefGoogle Scholar
  95. Whincup PH, Gilg JA, Emberson JR, Jarvis MJ, Feyerabend C, Bryant A, Walker M, Cook DG (2004) Passive smoking and risk of coronary heart disease and stroke: prospective study with cotinine measurement. BMJ 329(7459):200–205PubMedCrossRefGoogle Scholar
  96. WHO (2004) Smoking and oral tobacco use. In: Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors, vol 1. World Health Organization, Geneva, Chapter 11Google Scholar
  97. Wilhelmsson C, Vedin JA, Elmfeldt D, Tibblin G, Wilhelmsen L (1975) Smoking and myocardial infarction. Lancet 1(7904):415–420PubMedCrossRefGoogle Scholar
  98. Wilson K, Gibson N, Willan A, Cook D (2000) Effect of smoking cessation on mortality after myocardial infarction: meta analysis of cohort studies. Arch Intern Med 160:939–944PubMedCrossRefGoogle Scholar
  99. Wolf PA, D’Agostino RB, Kannel WB, Bonita R, Belanger AJ (1988) Cigarette smoking as a risk factor for stroke. The Framingham Study. JAMA 259(7):1025–1029PubMedCrossRefGoogle Scholar
  100. Woloshin S, Schwartz LM, Welch HG (2008) The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J Natl Cancer Inst 100(12):845–853PubMedCrossRefGoogle Scholar
  101. Yatsuya H, Folsom AR (2010) Risk of incident cardiovascular disease among users of smokeless tobacco in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 172(5):600–605PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  1. 1.Sackler Faculty of Medicine, Department of Epidemiology and Preventive MedicineTel Aviv UniversityTel AvivIsrael
  2. 2.Sackler Faculty of Medicine, Department of Health PromotionTel Aviv UniversityTel AvivIsrael
  3. 3.Sackler Faculty of Medicine, Department of Epidemiology and Preventive Medicine, School of Public HealthTel Aviv UniversityTel AvivIsrael

Personalised recommendations